Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HIPANC-002 - Observational Performance Study of Transcriptome-Based OncoTreat/OncoTarget Testing With Patient-Derived Organoids in Metastatic Pancreatic Cancer

NCT06615830 is registered in ClinicalTrials.gov with Prof. Dr. med. Dres. h.c. Jan Schmidt, MME as lead sponsor.

NCT NCT06615830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06615830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HIPANC-002 - Observational Performance Study of Transcriptome-Based OncoTreat/OncoTarget Testing With Patient-Derived Organoids in Metastatic Pancreatic Cancer
Lead sponsor
Prof. Dr. med. Dres. h.c. Jan Schmidt, MME
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
January 31, 2031
Enrollment
185 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas neoplasms, pancreatic adenocarcinoma metastatic, pancreatic cancer metastatic, pancreatic neoplasms